Tower Research Capital (TRC)’s Bellevue Life Sciences Acquisition Corp. Unit BLACU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10
| Closed | -$116 | – | 6011 |
|
|
2024
Q4 | $116 | Hold |
10
| – | – | ﹤0.01% | 5450 |
|
|
2024
Q3 | $110 | Hold |
10
| – | – | ﹤0.01% | 5505 |
|
|
2024
Q2 | $109 | Hold |
10
| – | – | ﹤0.01% | 5480 |
|
|
2024
Q1 | $110 | Hold |
10
| – | – | ﹤0.01% | 5647 |
|
|
2023
Q4 | $106 | Hold |
10
| – | – | ﹤0.01% | 5708 |
|
|
2023
Q3 | $108 | Hold |
10
| – | – | ﹤0.01% | 5719 |
|
|
2023
Q2 | $108 | Hold |
10
| – | – | ﹤0.01% | 5787 |
|
|
2023
Q1 | $0 | Buy |
+10
| New | – | ﹤0.01% | 6399 |
|